Japanese pharmaceutical group Takeda, which is located in Vienna, hopes to have through 9-18 months to complete the development of a vaccine against coronavirus.
It is reported by the Austrian public teleradioveschateley .
According to a leading virologist Takeda Thomas Kryla, the company hopes that the drug will be approved within 9-18 months.
Krill added that the company, which specializiruetsya on the development obtained from donor plasma medicines, has previously engaged in the development of antibody-based drugs against “avian” and “swine.”
We would ask patients who have had Covid-19 and fully experienced the infection and is now healthy to donate plasma. From this plasma by fractionation” will be concentrated and stored antibodies. Then the patients patients receive antibodies from the plasma in a concentrated form,
Myths and truth about coronavirus / Infographic 24 Channel
More news regarding the treatment, medicine, nutrition, healthy lifestyle and much more – see Health.